您的位置: 首页 > 农业专利 > 详情页

Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorylase Inhibitors In Combination With Radiation
专利权人:
Inc.;Shuttle Pharmaceuticals
发明人:
Scott Grindrod,Mira Jung,Olga Timofeeva,Milton Brown,Anatoly Dritschilo
申请号:
US16475999
公开号:
US20190343859A1
申请日:
2018.01.09
申请国别(地区):
US
年份:
2019
代理人:
摘要:
Methods and formulations are provided for treating cancer and neoplastic diseases in conjunction with radiation therapy where such methods and formulations include a combination of a radiosensitizing agent that is metabolized by thymidine phosphorylase and a thymidine phosphorylase inhibitor that increases the half-life of the radiosensitizing agent.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充